MapLight Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.8% | +17.7% | +8.1% | +3.7% | -14.4% | -18.1% | +0.0% | +2.9% | +15.7% | -9.3% | – | |
| – | – | – | – | -39.5% | – | – | – | +28,316.8% | -72.9% | -10.5% | – | |
| – | – | – | -406.0% | – | – | – | – | – | – | +2,585.3% | – | |
| – | -97.4% | +14,300.0% | +29.9% | -71.7% | -100.0% | – | -53.0% | +1,112.9% | -93.6% | -8.3% | – | |
| – | -97.4% | +6,090,900.0% | – | +274.9% | +15.8% | -53.5% | -877.7% | +78.9% | – | -9.4% | – | |
| – | +11,995,900.0% | -101.4% | -87.8% | – | -1,040.0% | +231.9% | – | +37.3% | -102.5% | – | – | |
| – | +1,035.3% | -200.0% | – | – | +359.7% | -133.3% | – | -156.8% | – | +77.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.